Chemotherapy ± Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy ± Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer
Authors
Keywords
-
Journal
ONCOLOGY
Volume 84, Issue 5, Pages 273-283
Publisher
S. Karger AG
Online
2013-02-23
DOI
10.1159/000343282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor immunosurveillance in human cancers
- (2011) Bernhard Mlecnik et al. CANCER AND METASTASIS REVIEWS
- Immunological monitoring of the tumor immunoenvironment for clinical trials
- (2011) Anatoli M. Malyguine et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
- (2011) N. Halama et al. CANCER RESEARCH
- Loss of Interleukin-10 or Transforming Growth Factor β Signaling in the Human Colon Initiates a T-Helper 1 Response Via Distinct Pathways
- (2011) Anne Jarry et al. GASTROENTEROLOGY
- Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro
- (2011) P. Correale et al. INTERNATIONAL JOURNAL OF CANCER
- IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN- Production
- (2011) A. C. Jaime-Ramirez et al. JOURNAL OF IMMUNOLOGY
- The prognostic impact of anti-cancer immune response: a novel classification of cancer patients
- (2011) Gabriela Bindea et al. Seminars in Immunopathology
- Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancer
- (2010) A. Sartore-Bianchi et al. CANCER TREATMENT REVIEWS
- Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
- (2010) M. Gonzalez-Aparicio et al. GUT
- Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor
- (2010) Anna Maria Orengo et al. INTERNATIONAL JOURNAL OF CANCER
- Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients
- (2010) Nikolaos Tsavaris et al. INVESTIGATIONAL NEW DRUGS
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Cellular Mediators of Inflammation: Tregs andTH17Cells in Gastrointestinal Diseases
- (2010) Franco Pandolfi et al. MEDIATORS OF INFLAMMATION
- IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
- (2010) Maya Eisenring et al. NATURE IMMUNOLOGY
- The effect of colorectal cancer upon host peripheral immune cell function
- (2009) C. F. M. Evans et al. Colorectal Disease
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now